Key Highlights

● CRM closed at $228.95 on 9 October 2026, and the $275.14 consensus target implies upside of about 20.2%.

● The consensus draws on 50 analysts, with targets from $160 to $400, while the second data set shows a higher $283.36 mean from 56 analysts.

● Market data lists 33 Buy, 14 Hold and three Sell ratings, a Moderate Buy consensus.

● Guggenheim, Stifel and Canaccord Genuity each raised to $300 in mid-September, and BMO raised to $285 from $250.

Salesforce, Inc. (NYSE:CRM), the cloud software and customer relationship management group, closed at $228.95 on Friday 9 October 2026. The company is a constituent of the S&P 500, and analysts cover the stock heavily, with targets above the share price.

What Is the Latest Analyst Price Target?

Market data reports a consensus price target of $275.14 from 50 analysts, with a high of $400.00 and a low of $160.00. Against the $228.95 close, that implies upside of about 20.2%. The second data set, which counts 56 analysts, shows a higher mean of $283.36 and a median of $282.50, with a high of $475 and a low of $160.

The gap between providers reflects different analyst samples and update times. Recent named targets mostly sit between $225 and $315, bracketing both means. The very high end of each range, $400 on market data and $475 on the second data set, appears to be an outlier and pulls the averages up.

What Are Wall Street Analysts Saying?

Ratings are positive overall. Market data lists 33 Buy, 14 Hold and three Sell ratings, a Moderate Buy consensus. The second data set shows 39 Buy or Strong Buy, 15 Hold and two Sell.

Many brokers raised targets in mid-September, according to market data. Guggenheim moved from $270 to $300, Stifel from $275 to $300, Canaccord Genuity from $270 to $300, BMO Capital from $250 to $285, Mizuho from $265 to $280 and Wells Fargo from $230 to $250 with an Equal Weight rating. DA Davidson set $225, RBC reiterated Sector Perform at $250 and Citizens JMP reiterated $315.

In August, Barclays raised from $236 to $276 and JPMorgan from $250 to $265. The second data set shows October updates from Citi at $263 with a Hold rating, TD Cowen at $300, Goldman Sachs at $271 and a new Yorkville Ives & Co initiation at $290. The direction of revisions has been upward, but the spread of views is wide.

What Could Help the Stock Reach the Price Target?

Bullish views typically rest on growth in AI products, data and subscription revenue, margin expansion and buybacks. Evidence of strong adoption of new products by large customers would likely support estimates. A recovery in sentiment towards enterprise software could also narrow the gap.

What Could Prevent the Stock Reaching the Target?

Concerns that artificial intelligence tools could reduce demand for traditional software seats, competition from larger technology groups, slower enterprise spending, and integration risks from acquisitions are the main risks. With 14 Hold ratings and three Sells on market data, and targets as low as $160, some analysts see limited upside.

What Should Investors Watch Next?

Items to watch include revenue growth, margins, guidance, adoption of AI products and further broker revisions, which could move the consensus in either direction.

Salesforce's Upward Revisions Meet a Wide Spread of Views

Salesforce closed at $228.95 on 9 October 2026, with the $275.14 consensus target about 20.2% higher and recent named targets mostly between $225 and $315, bracketing both data sets' means. The direction of revisions has been upward, with mid-September raises from Guggenheim, Stifel, Canaccord, BMO and Mizuho and October updates from Citigroup, TD Cowen and Goldman Sachs, but 14 Hold ratings, three Sells and targets as low as $160 show the spread of views is wide.